|
QKI expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.486300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.619100E-03 |
| Normal-vs-Stage2 |
3.822000E-01 |
| Normal-vs-Stage3 |
8.363600E-01 |
| Normal-vs-Stage4 |
7.358800E-01 |
| Stage1-vs-Stage2 |
7.198200E-01 |
| Stage1-vs-Stage3 |
3.620000E-02 |
| Stage1-vs-Stage4 |
4.392400E-02 |
| Stage2-vs-Stage3 |
4.693600E-01 |
| Stage2-vs-Stage4 |
5.033200E-01 |
| Stage3-vs-Stage4 |
9.164800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.675500E-02 |
| Normal-vs-AfricanAmerican |
3.874400E-01 |
| Normal-vs-Asian |
5.194800E-01 |
| Caucasian-vs-AfricanAmerican |
1.503800E-02 |
| Caucasian-vs-Asian |
8.597200E-01 |
| AfricanAmerican-vs-Asian |
2.585600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.364400E-02 |
| Normal-vs-Female |
1.494410E-01 |
| Male-vs-Female |
7.694000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.865400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.771960E-02 |
| Normal-vs-Age(61-80Yrs) |
2.272600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.383200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.666800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.750000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.191200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.695840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.985800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.594630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.177950E-02 |
| Normal-vs-Grade 2 |
2.184400E-03 |
| Normal-vs-Grade 3 |
8.088200E-01 |
| Normal-vs-Grade 4 |
6.442800E-01 |
| Grade 1-vs-Grade 2 |
2.980600E-01 |
| Grade 1-vs-Grade 3 |
1.560220E-03 |
| Grade 1-vs-Grade 4 |
3.343400E-03 |
| Grade 2-vs-Grade 3 |
1.660500E-03 |
| Grade 2-vs-Grade 4 |
2.821700E-03 |
| Grade 3-vs-Grade 4 |
4.693000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.244500E-04 |
| Normal-vs-ccB subtype |
5.338000E-01 |
| ccA subtype-vs-ccB subtype |
7.220900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.140500E-02 |
| Normal-vs-N1 |
8.020600E-01 |
| N0-vs-N1 |
6.540800E-01 |
|
|
